Can doctors prescribe Mounjaro for weight loss in the UK?

The myth worth correcting: Mounjaro is not GP-only or NHS-only

A lot of people searching this question have been told (or have assumed) that only their own GP can prescribe Mounjaro, and that if the GP says no, that is the end of it. That assumption is worth setting aside. Any GPhC-registered Independent Prescriber with the appropriate competency can prescribe tirzepatide for weight management, and that includes prescribers working at regulated private clinics and online pharmacies, not only those working in NHS GP surgeries.

The medicine itself has held a full MHRA licence since 2023, covering weight management alongside a reduced-calorie diet and increased physical activity. NHS guidance on tirzepatide confirms the licensed indications clearly. So the question is not really can a doctor prescribe it (legally and clinically, yes) but which route makes sense for your situation, and our page on whether doctors can prescribe Mounjaro walks through exactly what that involves.

If you have been told by your GP that they cannot or will not prescribe Mounjaro, that may reflect NHS funding rules, local commissioning decisions, or simply that the practice has not yet opted into the new prescribing contract. It does not mean you are ineligible. Many people explore private prescribing for exactly this reason, and it is a straightforwardly legal option when done through a properly registered pharmacy.

NHS prescribing: who qualifies and where things stand in 2024–2026

On the NHS, the picture is more layered. NICE's technology appraisal of tirzepatide, TA1026, published in December 2024, recommends it for adults with a BMI of 35 or above plus at least one weight-related comorbidity, conditions from a defined list that includes high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease and type 2 diabetes. Ethnic-background adjustments reduce those thresholds by 2.5 kg/m² for some groups under UK guidance.

NHS England is rolling this out in phases. The first cohort (BMI ≥40 with four or more of the qualifying conditions) became eligible in June 2025. A second cohort (BMI 35–39.9, four or more conditions) opened in June 2026. Later phases will extend access further, but the full rollout runs to 2027 and beyond. From April 2026, some GP practices may prescribe directly under a new contract, though participation is voluntary and varies by area.

If you are curious whether you might qualify under the NHS criteria, the page on NHS Mounjaro entitlement covers the phase schedule in detail. The honest reality is that most people asking this question right now do not yet meet the NHS thresholds, or their practice is not yet participating, which is why private prescribing exists and is growing.

Private prescribing: how a legitimate prescription actually works

Through a regulated private route, the licensed eligibility criteria are broader: BMI ≥30, or ≥27 with a qualifying weight-related condition. A prescriber reviews your medical history, current medicines, relevant conditions and (critically) verifies your identity and weight before issuing any prescription. That verification step matters. Some services skip it; that is a red flag, not a convenience.

At nume, every consultation is reviewed the same day by a GPhC-registered Independent Prescriber, a real clinician reading your answers, not software making a decision. Identity is confirmed through photo-ID checks and live video weight verification. If the prescriber approves treatment, the prescription is issued and the medicine dispatched the same day (for orders placed before 12pm on a working day), arriving via tracked DPD delivery the next working day. There are no subscriptions and no hidden fees; every repeat order goes through clinical re-review.

You can find more about buying Mounjaro online safely and what to look for in a legitimate provider. The short version: check any online pharmacy on the GPhC register at pharmacyregulation.org, and treat any service offering Mounjaro without a clinical assessment as a serious warning sign. The MHRA has warned repeatedly about counterfeit weight-loss pens (some containing insulin) seized from unregistered sellers.

Does the type of prescriber change the medicine you receive?

No. Whether your prescription comes from an NHS GP, a hospital specialist or a private Independent Prescriber, the medicine is tirzepatide, manufactured by Eli Lilly and supplied through the licensed UK supply chain. The pen format, the strength options (2.5mg through to 15mg), and the clinical monitoring expectations are the same. What differs is the funding, the eligibility threshold applied, and the wrap-around support provided alongside treatment.

This is worth knowing if you have been considering asking your GP to prescribe Mounjaro and wondering whether a private prescription would somehow be a lesser option. It is not. Clinically, you receive the same licensed medicine. The question is simply which route is open to you and which moves at a pace that suits your situation. If you want to understand the full treatment picture before deciding, our Mounjaro overview lays it out without the jargon.

We know this kind of research can feel exhausting, especially if you have already been turned away once or told to come back when your BMI is higher. If a private consultation makes sense for you, the next step is straightforward: start your free consultation and let our prescribers assess whether Mounjaro is clinically appropriate for you.